CD80 and neoplasm: Even in the absence of tumour cell apoptosis, cGAMP treatment-induced DC maturation, manifested by 4-, 6-, and 2-fold increases of CD80, CD86, and MHC-II, respectively, compared to PBS treatment (Fig. 10e-g).